Finistere portfolio company, BioLumic, a developer of a sustainable ultraviolet yield enhancement platform, has extended its Series A led by Finistere Ventures to include an investment of $1.5 million from Canopy Rivers. The additional capital brings the oversubscribed funding round to $6.7 million.
Read MoreNew Zealand agtech statup BioLumic has raised a $5 million Series A round to commercialize its ultraviolet light-based seed and seedling treatments. The round was led by agtech VC Finistere Ventures And Radicle Growth Acceleration Fund.
Read MorePalmerston North's BioLumic has been backed by $6.5 million worth of investments from around the world. The biological company confirmed its new financial backing on Wednesday night and announced a plan to "aggressively" expand its staff at both its New Zealand and United States offices.
Read More